Li Qing-Zhong, Tan Jia-Xin, Qin Quan-Zhi, Ruan Guo-Tian, Deng Teng, Gong Yi-Zhen
Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530021, China.
Guangxi Medical University, Nanning, Guangxi 530021, China.
Am J Prev Cardiol. 2025 May 2;22:101003. doi: 10.1016/j.ajpc.2025.101003. eCollection 2025 Jun.
Metabolic dysfunction-associated steatotic liver disease (MASLD) impacts >30 % of the world's population, imposing significant societal and familial burdens. Arterial stiffness is a known risk factor for various metabolic disorders, and early-onset MASLD may be linked to heightened arterial stiffness. However, studies investigating the link between arterial stiffness and MASLD are limited.
This study utilized data from the NHANES database, focusing on young adults aged 20 to 45 years, spanning from 2005 to 2018. The Fatty Liver Index (FLI) was used to diagnose MASLD, and the estimated Pulse Wave Velocity (ePWV) was utilized to assess arterial stiffness. The association between MASLD and arterial stiffness was analyzed using weighted multiple logistic regression models and restricted cubic splines. Sensitivity analyses were performed to evaluate the stability of the observed relationship.
The study included 5 522 participants, with 3 415 serving as controls and 2 107 diagnosed with MASLD. The two groups differed significantly in age, income, and comorbidities, including hypertension and diabetes. The mean ePWV was 6.79 ( = 0.71) in the MASLD group and 6.33 ( = 0.57) in the control group, respectively. Adjusted weighted logistic regression models revealed that individuals in the high ePWV group (ePWV ≥ 6.559) had a 2.39-fold increased risk of onset compared to those in the low ePWV group (ePWV < 6.559), with statistical significance ( < 0.05). Restricted cubic splines (RCS) also demonstrated a positive linear correlation between ePWV and MASLD. Sensitivity analysis validated the strong correlation between ePWV and MASLD, while subgroup analysis demonstrated a positive association between ePWV and MASLD across most subgroups (OR > 1).
The study indicates a strong association between arterial stiffness, as measured by ePWV, and MASLD in young adults. The results suggest that targeting arterial stiffness could aid in preventing and managing MASLD.
代谢功能障碍相关脂肪性肝病(MASLD)影响着全球超过30%的人口,给社会和家庭带来了沉重负担。动脉僵硬度是各种代谢紊乱的已知危险因素,早发性MASLD可能与动脉僵硬度增加有关。然而,研究动脉僵硬度与MASLD之间联系的研究有限。
本研究利用了美国国家健康与营养检查调查(NHANES)数据库的数据,研究对象为2005年至2018年期间年龄在20至45岁之间的年轻人。采用脂肪肝指数(FLI)诊断MASLD,并利用估计脉搏波速度(ePWV)评估动脉僵硬度。使用加权多元逻辑回归模型和受限立方样条分析MASLD与动脉僵硬度之间的关联。进行敏感性分析以评估观察到的关系的稳定性。
该研究纳入了5522名参与者,其中3415名作为对照组,2107名被诊断为MASLD。两组在年龄、收入和合并症(包括高血压和糖尿病)方面存在显著差异。MASLD组的平均ePWV为6.79(标准差 = 0.71),对照组为6.33(标准差 = 0.57)。调整后的加权逻辑回归模型显示,与低ePWV组(ePWV < 6.559)相比,高ePWV组(ePWV ≥ 6.559)的个体发病风险增加了2.39倍,具有统计学意义(P < 0.05)。受限立方样条(RCS)也显示ePWV与MASLD之间存在正线性相关。敏感性分析验证了ePWV与MASLD之间的强相关性,而亚组分析表明,在大多数亚组中ePWV与MASLD之间存在正相关(OR > 1)。
该研究表明,通过ePWV测量的动脉僵硬度与年轻人的MASLD之间存在密切关联。结果表明,针对动脉僵硬度可能有助于预防和管理MASLD。